Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade

Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade

kidneycancer

3 years
559 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paula Ragan, CEO, X4 Pharmaceuticals presents Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade at the 2016 annual International Kidney Cancer Symposium.
Up Next Autoplay